TrialCirculation2019

Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.

Matthew T Roe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.